First-pass radionuclide assessment of right and left ventricular performance in patients with cardiac and pulmonary disease.
First-pass radionuclide angiocardiography allows noninvasive determination of right and left ventricular performance from a single study. Analysis is made from the high frequency components of the regional radionuclide time-activity curves. Both regional and global ventricular performance can be assessed at rest and during exercise. Sequential studies can be performed to evaluate therapeutic interventions. This technique has been applied in a broad spectrum of patients with cardiac and pulmonary disease and has been shown to have major clinical impact.
D000328:Adult; D002302:Cardiac Output / Q000187:drug effects; D003971:Diastole; D004317:Doxorubicin / Q000009:adverse effects; D006331:Heart Diseases / Q000139:chemically induced / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006352:Heart Ventricles / Q000000981:diagnostic imaging* / Q000503:physiopathology; D006801:Humans; D008171:Lung Diseases / Q000000981:diagnostic imaging* / Q000503:physiopathology; D008722:Methods; D005082:Physical Exertion; D011877:Radionuclide Imaging; D013599:Systole
D004317:Doxorubicin